Data submission and quality in microarray-based microRNA profiling.

BACKGROUND Public sharing of scientific data has assumed greater importance in the omics era. Transparency is necessary for confirmation and validation, and multiple examiners aid in extracting maximal value from large data sets. Accordingly, database submission and provision of the Minimum Information About a Microarray Experiment (MIAME)(3) are required by most journals as a prerequisite for review or acceptance. METHODS In this study, the level of data submission and MIAME compliance was reviewed for 127 articles that included microarray-based microRNA (miRNA) profiling and were published from July 2011 through April 2012 in the journals that published the largest number of such articles--PLOS ONE, the Journal of Biological Chemistry, Blood, and Oncogene--along with articles from 9 other journals, including Clinical Chemistry, that published smaller numbers of array-based articles. RESULTS Overall, data submission was reported at publication for <40% of all articles, and almost 75% of articles were MIAME noncompliant. On average, articles that included full data submission scored significantly higher on a quality metric than articles with limited or no data submission, and studies with adequate description of methods disproportionately included larger numbers of experimental repeats. Finally, for several articles that were not MIAME compliant, data reanalysis revealed less than complete support for the published conclusions, in 1 case leading to retraction. CONCLUSIONS These findings buttress the hypothesis that reluctance to share data is associated with low study quality and suggest that most miRNA array investigations are underpowered and/or potentially compromised by a lack of appropriate reporting and data submission.

[1]  Ha Won Kim,et al.  microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4 , 2011, PloS one.

[2]  J. Licht,et al.  miR-27b controls venous specification and tip cell fate. , 2012, Blood.

[3]  J. Brooks.  Why most published research findings are false: Ioannidis JP, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece , 2008 .

[4]  W. Liao,et al.  MiR-194 Regulates Chondrogenic Differentiation of Human Adipose-Derived Stem Cells by Targeting Sox5 , 2012, PloS one.

[5]  M. Sur,et al.  miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. , 2011, Nature neuroscience.

[6]  J. Clements,et al.  miRNA Profiles of Monocyte-Lineage Cells Are Consistent with Complicated Roles in HIV-1 Restriction , 2012, Viruses.

[7]  Sergio Contrino,et al.  ArrayExpress—a public repository for microarray gene expression data at the EBI , 2004, Nucleic Acids Res..

[8]  Kazuho Ikeo,et al.  CIBEX: center for information biology gene expression database. , 2003, Comptes rendus biologies.

[9]  C. Begley,et al.  Drug development: Raise standards for preclinical cancer research , 2012, Nature.

[10]  J. Clements,et al.  Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients , 2012, Retrovirology.

[11]  Y. Jeng,et al.  Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling , 2013, Oncogene.

[12]  H. Feilotter,et al.  miR-193b Regulates Mcl-1 in Melanoma. , 2011, The American journal of pathology.

[13]  M. Fabbri.  miRNAs as molecular biomarkers of cancer , 2010, Expert review of molecular diagnostics.

[14]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[15]  Alvis Brazma,et al.  Minimum Information About a Microarray Experiment (MIAME) – Successes, Failures, Challenges , 2009, TheScientificWorldJournal.

[16]  Donavan T. Cheng,et al.  Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression , 2012, PloS one.

[17]  S. Booth,et al.  MicroRNA 146a (miR-146a) Is Over-Expressed during Prion Disease and Modulates the Innate Immune Response and the Microglial Activation State , 2012, PloS one.

[18]  I. Hewlett,et al.  Identification of XMRV Infection-Associated microRNAs in Four Cell Types in Culture , 2012, PloS one.

[19]  J. Clements,et al.  A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease , 2011, AIDS.

[20]  D. Xie,et al.  MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. , 2012, Journal of hepatology.

[21]  Hui-Yun Wang,et al.  Downregulation of Six MicroRNAs Is Associated with Advanced Stage, Lymph Node Metastasis and Poor Prognosis in Small Cell Carcinoma of the Cervix , 2012, PloS one.

[22]  F. Prinz,et al.  Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.

[23]  Santanu Raychaudhuri.  MicroRNAs Overexpressed in Growth-Restricted Rat Skeletal Muscles Regulate the Glucose Transport in Cell Culture Targeting Central TGF-β Factor SMAD4 , 2012, PloS one.

[24]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[25]  H. Le,et al.  Comparative Expression Profile of miRNA and mRNA in Primary Peripheral Blood Mononuclear Cells Infected with Human Immunodeficiency Virus (HIV-1) , 2011, PloS one.

[26]  J. Clements,et al.  Evidence for miRNA expression differences of HIV-1-positive, treatment-naive patients and elite suppressors: a re-analysis. , 2012, Blood.

[27]  Kenneth P. Nephew,et al.  Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells , 2012, PloS one.

[28]  Link,et al.  Willingness to share research data is related to the strength of the evidence and the quality of reporting of statistical results , 2014 .

[29]  H. Haider,et al.  Efficient Non-Viral Reprogramming of Myoblasts to Stemness with a Single Small Molecule to Generate Cardiac Progenitor Cells , 2011, PloS one.

[30]  C. Ball,et al.  Repeatability of published microarray gene expression analyses , 2009, Nature Genetics.

[31]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[32]  M. Caligiuri,et al.  Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. , 2012, Blood.

[33]  Guoqiang Sun,et al.  Genome-Wide Profiling Identified a Set of miRNAs that Are Differentially Expressed in Glioblastoma Stem Cells and Normal Neural Stem Cells , 2012, PloS one.

[34]  Z. Herceg,et al.  Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.

[35]  John P A Ioannidis,et al.  Clinical outcome prediction by microRNAs in human cancer: a systematic review. , 2012, Journal of the National Cancer Institute.

[36]  L. Lopalco,et al.  Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. , 2012, Blood.

[37]  V. Álvarez,et al.  Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations. , 2011, Clinical chemistry.